MANILA — The doctor on the phone asked Ratish Sharma how old he was and how long he had been taking Telma 40. That was it. Approval granted.
The delivery came in under ten minutes. Sharma did not have a prescription.
The platform’s process required one — theoretically. But the call served as a substitute. The system worked, on paper.
The question nobody asked: How did we get here? Quick-commerce apps were not built for healthcare.
They started with groceries, toilet paper, snacks. The model was speed. A customer wants instant noodles, the app delivers in minutes.
That infrastructure — the dark stores, the riders, the real-time inventory — now carries prescription drugs. The shift happened quietly. One day you ordered shampoo.
The next, the same app offered blood pressure medication. The Philippines has a law.
Certain medicines require a prescription. Telma 40, which contains telmisartan, is one of them. It is used to treat hypertension.
The drug affects kidney function, interacts with other medications, and can cause side effects if misused. A doctor is supposed to assess whether it is appropriate.
That assessment takes more than a few questions about age and duration of use. But the app’s in-house doctor — a term the platform uses — did not ask about medical history, current medications, or kidney function. The call lasted seconds.
The medicine arrived. The convenience was real. So was the risk.
Leading doctors interviewed by Times Now Digital said medicines should be easier to access, especially for elderly patients and those with chronic conditions. But they also said prescription safeguards cannot be bypassed.
The tension is old. The technology is new. Quick-commerce platforms expanded into healthcare because the market demanded it.
Filipino families, especially those outside Metro Manila, often struggle to get prescriptions filled. Pharmacies close early.
Doctors are far. Traffic is brutal. An app that delivers in ten minutes solves a real problem.
It also creates one. The verification call is the safeguard. It is the only check between a patient and a prescription drug.
Sharma’s experience suggests that check is weak. A person without hypertension, if they answered the questions convincingly, could probably get the drug.
The platform followed its own process. The process itself may be the problem. Doctors interviewed by Times Now Digital did not name the platform.
They did not name Sharma either. They spoke generally about the risks of buying prescription medicines online.
The risks are not theoretical. Telmisartan can cause dizziness, kidney damage, or dangerous drops in blood pressure if taken by someone who does not need it. A brief phone call cannot screen for those outcomes.
The app’s system is not unique. Other platforms use similar models. An in-house doctor — often a general practitioner working remotely — conducts a quick consultation.
The consultation is free. The approval is fast.
The medicine arrives before a traditional prescription could be written. Speed is the selling point. It is also the danger.
Sharma ordered Telma 40 because he was out. He had been taking it for a while.
He knew his dose. The system worked for him. But the system is designed for speed, not for patients who do not know their dose, or who are trying a drug for the first time, or who have other conditions the drug could worsen.
The platform’s process looks like a safeguard. A doctor calls. A prescription is required.
But the call is brief, and the prescription requirement is waived if the call happens. The line between convenience and recklessness is thin.
Quick-commerce apps crossed it without anyone noticing.
